Ron Baron acquired 3.28 Million Bio-Techne shares worth $169 Million. That's 0.47% of their equity portfolio (40th largest holding). The investor owns 2.07% of the outstanding Bio-Techne stock. The first Bio-Techne trade was made in Q4 2014. Since then Ron Baron bought shares thirteen more times and sold shares on 27 occasions. The investor's estimated purchase price is $625 Million, resulting in a loss of 73%.
Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2023 investor letter. A copy of the same can be downloaded...
Guru stock highlight Check out Ron Baron Stock Picks » Download GuruFolio Report of Ron Baron (Updated on 11/08/2022) Related Stocks: TECH ,
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2022 investor letter – a copy of which can be downloaded here.
No summary available.